Company intelligence / Profile preview

UV Flu Technologies

Lincolnshire, Illinois, United States

Ownership: Private
Development stage: Other

Overview

UV Flu Technologies commercializes FDA-cleared, class II medical device air purification systems (ViraTech, RXAir) shown to destroy over 99% of airborne bacteria and viruses in independent laboratory tests. Their devices are used in clinical, institutional, and home settings as adjuncts for infection control and air quality improvement[5][8].

Therapeutic areas: ImmunologyPulmonologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

UCES (distribution)myVBO (branding and marketing support)[8]

Beyond the preview

Go deeper on UV Flu Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UV Flu Technologies.

Explore the full profile